| Label | Element | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INVESCO Health Care Fund | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk/Return [Heading] | oef_RiskReturnHeading | Fund Summary | ||||||||||
| Objective [Heading] | oef_ObjectiveHeading | Investment Objective(s) | ||||||||||
| Objective, Primary [Text Block] | oef_ObjectivePrimaryTextBlock | The Fund’s investment objective is long-term growth of capital.
|
||||||||||
| Expense Heading [Optional Text] | oef_ExpenseHeading | Fees and Expenses of the Fund | ||||||||||
| Expense Narrative [Text Block] | oef_ExpenseNarrativeTextBlock | This table describes the fees and expenses that you may pay if you buy, hold and sell shares of the Fund.
The table and Examples below do not reflect any transaction fees that may be charged by financial intermediaries or commissions that a shareholder may be required to pay directly to its financial intermediary when buying or selling Class Y or Class R6 shares. You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least $50,000 in the Invesco Funds. More information about these and other discounts is available from your financial professional and in the section “Shareholder Account Information – Initial Sales Charges (Class A Shares Only)” on page A-3 of the prospectus and the section “Purchase, Redemption and Pricing of Shares – Purchase and Redemption of Shares” on page L-1 of the statement of additional information (SAI).
|
||||||||||
| Shareholder Fees Caption [Optional Text] | oef_ShareholderFeesCaption | Shareholder Fees (fees paid directly from your investment) | ||||||||||
| Operating Expenses Caption [Optional Text] | oef_OperatingExpensesCaption | Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment) | ||||||||||
| Expenses Deferred Charges [Text Block] | oef_ExpensesDeferredChargesTextBlock | A contingent deferred sales charge may apply in some cases. See “Shareholder Account Information-Contingent Deferred Sales Charges (CDSCs).” | ||||||||||
| Expense Breakpoint Discounts [Text] | oef_ExpenseBreakpointDiscounts | You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least $50,000 in the Invesco Funds. | ||||||||||
| Expense Breakpoint, Minimum Investment Required [Amount] | oef_ExpenseBreakpointMinimumInvestmentRequiredAmount | $ 50,000 | ||||||||||
| Expenses Restated to Reflect Current [Text] | oef_ExpensesRestatedToReflectCurrent | Other Expenses” have been restated to reflect current fees. | ||||||||||
| Expense Example [Heading] | oef_ExpenseExampleHeading | Example. | ||||||||||
| Expense Example Narrative [Text Block] | oef_ExpenseExampleNarrativeTextBlock | This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods. This Example does not include commissions and/or other forms of compensation that investors may pay on transactions in Class Y and Class R6 shares. The Example also assumes that your investment has a 5% return each year and that the Fund’s operating expenses remain the same.
Although your actual costs may be higher or lower, based on these assumptions, your costs would be:
|
||||||||||
| Expense Example, No Redemption, By Year, Caption [Text] | oef_ExpenseExampleNoRedemptionByYearCaption | You would pay the following expenses if you did not redeem your shares: | ||||||||||
| Portfolio Turnover [Heading] | oef_PortfolioTurnoverHeading | Portfolio Turnover. | ||||||||||
| Portfolio Turnover [Text Block] | oef_PortfolioTurnoverTextBlock | The Fund pays transaction costs, such as commissions, when it buys and sells securities (or “turns over” its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Fund shares are held in a taxable account. These costs, which are not reflected in annual fund operating expenses or in the Example, affect the Fund’s performance. During the most recent fiscal year, the Fund’s portfolio turnover rate was 59% of the average value of its portfolio.
|
||||||||||
| Portfolio Turnover, Rate | oef_PortfolioTurnoverRate | 59.00% | ||||||||||
| Strategy [Heading] | oef_StrategyHeading | Principal Investment Strategies of the Fund | ||||||||||
| Strategy Narrative [Text Block] | oef_StrategyNarrativeTextBlock | The Fund invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities.
The Fund will concentrate its investments in the securities of domestic and foreign issuers in the health care industry. The Fund uses various criteria to determine whether an issuer is engaged in health care-related industries, including whether (1) it derives 50% or more of its gross income or its net sales from activities in the health care industry; (2) it devotes 50% or more of its assets to producing revenues from the health care industry; or (3) based on other available information, the Fund’s portfolio managers determine that its primary business is within the health care industry. Such other available information may include industry classifications from any one or more third-party providers, such as those using the Global Industry Classification Standard (GICS®), the North American Industry Classification System (NAICS), or the Bloomberg Industry Classification System (BICS).
Issuers engaged in health care-related industries include those that design, provide, distribute, manufacture, or sell products or services used for or in connection with health care or medicine (such as pharmaceutical issuers, biotechnology research firms, companies that make or sell medical products, and companies that own or operate health care facilities and systems).
The Fund invests primarily in equity securities, including common and preferred stock, and depositary receipts.
The Fund may invest in the securities of issuers of all capitalization sizes and may invest a significant amount of its net assets in the securities of small- and mid-capitalization issuers.
The Fund may invest in securities of foreign issuers including up to 20% of its net assets in securities of issuers located in emerging markets countries, i.e., those that are generally in the early stages of their industrial
cycles. The Fund can invest in derivative instruments, including forward foreign currency contracts. The Fund can use forward foreign currency contracts to seek to hedge against adverse movements in the foreign currencies in which portfolio securities are denominated.
In selecting securities for the Fund, the portfolio managers use a research-oriented bottom-up investment approach, focusing on issuer fundamentals and the strength of an individual issuer before considering the impact of overall economic, market, sector or industry trends. This approach includes analysis of a company's financial statements and management structure and consideration of the company's operations, product
development, and its industry position. The portfolio managers currently focus on companies that the portfolio managers believe are characterized by industry leadership, market share growth, high caliber management teams, sustainable competitive advantages, and strong growth themes or new innovative products or services. The portfolio managers monitor individual issuers for changes in the factors above, which may trigger a decision to sell a security, but does not require a decision to do so. The factors considered by the portfolio managers may vary in particular cases and may change over time.
|
||||||||||
| Bar Chart and Performance Table [Heading] | oef_BarChartAndPerformanceTableHeading | Performance Information | ||||||||||
| Performance Narrative [Text Block] | oef_PerformanceNarrativeTextBlock |
The bar chart and performance table provide an indication of the risks of investing in the Fund. The bar chart shows changes in the performance of the Fund from year to year as of December 31. The performance table compares the Fund’s performance to that of style-specific benchmarks and a broad-based securities market benchmark (in that order). The Fund's past performance (before and after taxes) is not necessarily an indication of its future performance.
Fund performance reflects any applicable fee waivers and expense reimbursements. Performance returns would be lower without applicable fee waivers and expense reimbursements.
All Fund performance shown assumes the reinvestment of dividends and capital gains and the effect of the Fund’s expenses.
Updated performance information is available on the Fund's website at www.invesco.com/us.
|
||||||||||
| Performance Information Illustrates Variability of Returns [Text] | oef_PerformanceInformationIllustratesVariabilityOfReturns | The bar chart and performance table provide an indication of the risks of investing in the Fund. | ||||||||||
| Performance Availability Website Address [Text] | oef_PerformanceAvailabilityWebSiteAddress | www.invesco.com/us | ||||||||||
| Performance Past Does Not Indicate Future [Text] | oef_PerformancePastDoesNotIndicateFuture | The Fund's past performance (before and after taxes) is not necessarily an indication of its future performance. | ||||||||||
| Bar Chart [Heading] | oef_BarChartHeading | Annual Total Returns | ||||||||||
| Bar Chart Narrative [Text Block] | oef_BarChartNarrativeTextBlock | The bar chart does not reflect sales loads. If it did, the annual total returns shown would be lower.
|
||||||||||
| Bar Chart Does Not Reflect Sales Loads [Text] | oef_BarChartDoesNotReflectSalesLoads | The bar chart does not reflect sales loads. If it did, the annual total returns shown would be lower. | ||||||||||
| Bar Chart Closing [Text Block] | oef_BarChartClosingTextBlock |
|
||||||||||
| Highest Quarterly Return, Label [Optional Text] | oef_HighestQuarterlyReturnLabel | Best Quarter | ||||||||||
| Highest Quarterly Return, Date | oef_BarChartHighestQuarterlyReturnDate | Dec. 31, 2019 | ||||||||||
| Highest Quarterly Return | oef_BarChartHighestQuarterlyReturn | 19.62% | ||||||||||
| Lowest Quarterly Return, Label [Optional Text] | oef_LowestQuarterlyReturnLabel | Worst Quarter | ||||||||||
| Lowest Quarterly Return, Date | oef_BarChartLowestQuarterlyReturnDate | Mar. 31, 2020 | ||||||||||
| Lowest Quarterly Return | oef_BarChartLowestQuarterlyReturn | (16.50%) | ||||||||||
| Performance Table Heading | oef_PerformanceTableHeading | Average Annual Total Returns (for the periods ended December 31, 2025) | ||||||||||
| Index No Deduction for Fees, Expenses, or Taxes [Text] | oef_IndexNoDeductionForFeesExpensesTaxes | (reflects no deduction for fees, expenses or taxes) | ||||||||||
| Performance Table Uses Highest Federal Rate | oef_PerformanceTableUsesHighestFederalRate | After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. | ||||||||||
| Performance Table Not Relevant to Tax Deferred | oef_PerformanceTableNotRelevantToTaxDeferred | Actual after-tax returns depend on an investor's tax situation and may differ from those shown, and after-tax returns shown are not relevant to investors who hold their Fund shares through tax-advantaged arrangements, such as 401(k) plans, 529 college savings plans or individual retirement accounts. | ||||||||||
| Performance Table One Class of after Tax Shown [Text] | oef_PerformanceTableOneClassOfAfterTaxShown | After-tax returns are shown for Class A shares only and after-tax returns for other classes will vary. | ||||||||||
| Performance Table Closing [Text Block] | oef_PerformanceTableClosingTextBlock | After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on an investor's tax situation and may differ from those shown, and after-tax returns shown are not relevant to investors who hold their Fund shares through tax-advantaged arrangements, such as 401(k) plans, 529 college savings plans or individual retirement accounts. After-tax returns are shown for Class A shares only and after-tax returns for other classes will vary.
|
||||||||||
| INVESCO Health Care Fund | Risk Lose Money [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | As with any mutual fund investment, loss of money is a risk of investing. | ||||||||||
| INVESCO Health Care Fund | Risk Not Insured [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | An investment in the Fund is not a deposit in a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency. | ||||||||||
| INVESCO Health Care Fund | Market Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock |
Market Risk. The market values of the Fund’s investments, and therefore the value of the Fund’s shares, will go up and down, sometimes rapidly or unpredictably. Market risk may affect a single issuer, industry or section of the economy, or it may affect the market as a whole. The value of the Fund’s investments may go up or down due to general market conditions that are not specifically related to the particular issuer. These market conditions may include real or perceived adverse economic conditions, changes in trade regulation or economic sanctions, changes in the general outlook for revenues or corporate earnings, changes in interest or currency rates, regional or global instability and uncertainty, natural or environmental disasters, widespread disease or other public health issues, war, military conflict, acts of terrorism, economic crisis or adverse investor sentiment generally, among others. Certain changes in the U.S. economy in particular, such as when the U.S. economy weakens or when its financial markets decline, may have a material adverse effect on global financial markets as a whole, and on the securities to which the Fund has exposure. Increasingly strained relations between the U.S. and foreign countries, including as a result of economic sanctions and tariffs, may also adversely affect U.S. issuers, as well as non-U.S. issuers.
During a general downturn in the financial markets, multiple asset classes may decline in value. When markets perform well, there can be no assurance that specific investments held by the Fund will rise in value.
|
||||||||||
| INVESCO Health Care Fund | Health Care Sector Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | Health Care Sector Risk. Factors such as extensive government regulation, restrictions on government reimbursement for medical expenses, rising costs of medical products, services and facilities, pricing pressure, an increased emphasis on outpatient services, a limited number of products, industry innovation, costs associated with obtaining and protecting patents, product liability and other claims, changes in technologies and other market developments can adversely affect companies in the health care sector.
|
||||||||||
| INVESCO Health Care Fund | Investing in Stocks Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | Investing in Stocks Risk. The value of the Fund’s portfolio may be affected by changes in the stock markets. Stock markets may experience significant short-term volatility and may fall or rise sharply at times. Adverse events in any part of the equity or fixed-income markets may have unexpected negative effects on other market segments. Different stock markets may behave differently from each other and U.S. stock markets may move in the opposite direction from one or more foreign stock markets.
The prices of individual stocks generally do not all move in the same direction at the same time. However, individual stock prices tend to go up and down more dramatically than those of certain other types of investments, such as bonds. A variety of factors can negatively affect the price of a particular company’s stock. These factors may include, but are not limited to: poor earnings reports, a loss of customers, litigation against the company, general unfavorable performance of the company’s sector or industry, or changes in government regulations affecting the company or its industry. To the extent that securities of a particular type are emphasized (for example foreign stocks, stocks of small- or mid-cap companies, growth or value stocks, or stocks of companies in a particular industry), Fund share values may fluctuate more in response to events affecting the market for those types of securities.
|
||||||||||
| INVESCO Health Care Fund | Preferred Securities Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock |
Preferred Securities Risk. There are special risks associated with investing in preferred securities compared to those applicable generally to equity securities. Preferred securities may be less liquid than many other securities, such as common stocks, and generally offer no voting rights with respect to the issuer. Preferred securities also may be subordinated to bonds or other debt instruments in an issuer’s capital structure, subjecting them to a greater risk of non-payment than more senior securities. Preferred securities may include provisions that permit the issuer, in its discretion, to defer or omit distributions for a certain period of time. If the Fund owns a security that is deferring or omitting its distributions, the Fund may be required to report the distribution on its tax returns, even though it may not have received any income. Further, preferred securities may lose substantial value due to the omission or deferment of dividend payments.
|
||||||||||
| INVESCO Health Care Fund | Small- and Mid-Capitalization Companies Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | Small- and Mid-Capitalization Companies Risk. Investing in securities of small- and mid-capitalization companies involves greater risk than customarily is associated with investing in larger, more established companies. Stocks of small- and mid-capitalization companies tend to be more vulnerable to changing market conditions, may have little or no operating history or track record of success, and may have more limited product lines and markets, less experienced management and fewer financial resources than larger companies. These companies’ securities may be more volatile and less liquid than those of more established companies. They may be more sensitive to changes in a company’s earnings expectations and may experience more abrupt and erratic price movements. Smaller companies’ securities often trade in lower volumes and in many instances, are traded over-the-counter or on a regional securities exchange, where the frequency and volume of trading is substantially less than is typical for securities of larger companies traded on national securities exchanges. Therefore, the securities of smaller companies may be subject to wider price fluctuations and it might be harder for the Fund to dispose of its holdings at an acceptable price when it wants to sell them. Since small- and mid-cap companies typically reinvest a high proportion of their earnings in their business, they may not pay dividends for some time, particularly if they are newer companies. It may take a substantial period of time to realize a gain on an investment in a small- or mid-cap company, if any gain is realized at all.
|
||||||||||
| INVESCO Health Care Fund | Foreign Investment Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock |
Foreign Investment Risk. Investments in the securities of non-U.S. issuers involve risks beyond those associated with investments in U.S. securities. Foreign securities may have relatively low market liquidity, greater market volatility, decreased publicly available information and less reliable financial information about issuers, and inconsistent and potentially less stringent accounting, auditing and financial reporting requirements and standards of practice, including recordkeeping standards, comparable to those applicable to domestic issuers. Foreign securities also are subject to the risks of possible seizure, expropriation, nationalization, political or social instability, changes in economic or taxation policies or other adverse political or economic developments (in which the Fund could lose its entire investments in a certain market) and the difficulty of enforcing obligations in other countries, including the possible adoption of foreign governmental restrictions such as exchange controls. Investments in foreign securities also may be subject to dividend withholding or confiscatory taxes, currency blockage and/or transfer restrictions and higher transactional costs. To the extent the Fund invests in securities denominated in foreign currencies, fluctuations in the value of the U.S. dollar relative to the values of other currencies may adversely affect investments in foreign securities and may negatively impact the Fund’s returns, unless the Fund has hedged its foreign currency exposure. Currency exchange rates may fluctuate significantly over short periods of time. Currency hedging strategies, if used, may not always be successful. Foreign companies generally may be subject to less stringent regulations than U.S. companies, including financial reporting requirements and auditing and accounting controls, and may therefore be more susceptible to fraud or corruption. There may be less public information available about foreign companies than U.S. companies, making it difficult to evaluate those foreign companies. From time to time, certain companies in which the Fund invests may operate in, or have dealings with, countries subject to sanctions or embargoes imposed by the U.S. government and the United Nations and/or in countries the U.S. government identified as state sponsors of terrorism. One or more of these companies may be subject to constraints under U.S. law or regulations that could negatively affect the company’s performance. Additionally, one or more of these companies could suffer damage to its reputation if the market identifies it as a company that invests or deals with countries that the U.S. government identifies as state sponsors of terrorism or is subject to sanctions.
|
||||||||||
| INVESCO Health Care Fund | Emerging Markets Investment Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | Emerging Markets Investment Risk. Investments in the securities of issuers in emerging market countries involve risks often not associated with investments in the securities of issuers in developed countries. Securities in emerging markets may be subject to greater price fluctuations than securities in more developed markets. Companies in emerging market countries generally may be subject to less stringent regulatory, disclosure, financial reporting, accounting, auditing and recordkeeping standards than companies in more developed countries. In addition, information about such companies may be less available and reliable. Emerging markets usually are subject to greater market volatility, political, social and economic instability, uncertainty regarding the existence of trading markets and more governmental limitations on foreign investment than are more developed markets. Securities law in many emerging market countries is relatively new and unsettled. Therefore, laws regarding foreign investment in emerging market securities, securities regulation, title to securities, and shareholder rights may change quickly and unpredictably, and the ability to bring and enforce actions, or to obtain information needed to pursue or enforce such actions, may be limited. In addition, the enforcement of systems of taxation at federal, regional and local levels in emerging market countries may be inconsistent and subject to sudden change. Investments in emerging market securities may be subject to additional transaction costs, delays in settlement procedures, unexpected market closures, and lack of timely information.
|
||||||||||
| INVESCO Health Care Fund | Issuer Focus Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | Issuer Focus Risk. Although the Fund is classified as a diversified fund, it may focus its investments in a relatively small number of issuers. The greater the Fund's exposure to any single investment or issuer, the greater the losses the Fund may experience upon any single economic, market, business, political, regulatory, or other occurrence. As a result, there may be more fluctuation in the price of the Fund's shares.
|
||||||||||
| INVESCO Health Care Fund | Derivatives Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | Derivatives Risk. The value of a derivative instrument depends largely on (and is derived from) the value of an underlying security, currency, commodity, interest rate, index or other asset (each referred to as an underlying asset). In addition to risks relating to the underlying assets, the use of derivatives may include other, possibly greater, risks, including counterparty, leverage and liquidity risks. Counterparty risk is the risk that the counterparty to the derivative contract will default on its obligation to pay the Fund the amount owed or otherwise perform under the derivative contract. Derivatives create leverage risk because they do not require payment up front equal to the economic exposure created by holding a position in the derivative. As a result, an adverse change in the value of the underlying asset could result in the Fund sustaining a loss that is substantially greater than the amount invested in the derivative or the anticipated value of the underlying asset, which may make the Fund’s returns more volatile and increase the risk of loss. Derivative instruments may also be less liquid than more traditional investments and the Fund may be unable to sell or close out its derivative positions at a desirable time or price. This risk may be more acute under adverse market conditions, during which the Fund may be most in need of liquidating its derivative positions. Derivatives may also be harder to value, less tax efficient and subject to changing government regulation that could impact the Fund’s ability to use certain derivatives or their cost. Derivatives strategies may not always be successful. For example, derivatives used for hedging or to gain or limit exposure to a particular market segment may not provide the expected benefits, particularly during adverse market conditions.
|
||||||||||
| INVESCO Health Care Fund | Depositary Receipts Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | Depositary Receipts Risk. Investing in depositary receipts involves the same risks as direct investments in foreign securities. In addition, the underlying issuers of certain depositary receipts are under no obligation to distribute shareholder communications or pass through any voting rights with respect to the deposited securities to the holders of such receipts. The Fund may therefore receive less timely information or have less control than if it invested directly in the foreign issuer.
|
||||||||||
| INVESCO Health Care Fund | Valuation Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | Valuation Risk. The price the Fund could receive upon the sale of a portfolio investment may differ from the Fund’s valuation of the investment, particularly for investments that trade in thin or volatile markets or that are valued using a fair valuation methodology. Financial information related to securities of non-U.S. issuers may be less reliable than information related to securities of U.S. issuers, which may make it difficult to obtain a current price for a non-U.S. security held by the Fund. When market quotations are not readily available for Fund investments, those investments are fair valued by the Adviser. There are multiple methods that can be used to fair value a portfolio investment and such methods may involve more subjectivity than the use of market quotations. The value established for an investment through fair valuation may be different from what would be produced if the investment had been valued using market quotations. In addition, there is no assurance that the Fund could sell a portfolio investment at any time for the value ascribed to it for purposes of calculating the Fund’s net asset value, and it is possible that the Fund could incur a loss because an investment is sold at a discount to its ascribed value. The ability to value investments may also be impacted by technological issues and/or errors by pricing services or other third-party service providers.
|
||||||||||
| INVESCO Health Care Fund | Management Risk [Member] | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Risk [Text Block] | oef_RiskTextBlock | Management Risk. The Fund is actively managed and depends heavily on the Adviser's judgment about markets, interest rates or the attractiveness, relative values, liquidity, or potential appreciation of particular investments made for the Fund’s portfolio. The Fund could experience losses if these judgments prove to be incorrect. There can be no guarantee that the Adviser's investment techniques or investment decisions will produce the desired results. Additionally, legislative, regulatory, or tax developments may adversely affect management of the Fund and, therefore, the ability of the Fund to achieve its investment objective.
|
||||||||||
| INVESCO Health Care Fund | INVESCO Health Care Fund - Class R | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Maximum Sales Charge Imposed on Purchases (as a percentage of Offering Price) | oef_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice | 0.00% | ||||||||||
| Maximum Deferred Sales Charge (as a percentage of Offering Price) | oef_MaximumDeferredSalesChargeOverOfferingPrice | 0.00% | ||||||||||
| Management Fees (as a percentage of Assets) | oef_ManagementFeesOverAssets | 0.64% | ||||||||||
| Distribution and Service (12b-1) Fees | oef_DistributionAndService12b1FeesOverAssets | 0.50% | ||||||||||
| Other Expenses (as a percentage of Assets): | oef_OtherExpensesOverAssets | 0.17% | [1] | |||||||||
| Acquired Fund Fees and Expenses | oef_AcquiredFundFeesAndExpensesOverAssets | 0.01% | ||||||||||
| Expenses (as a percentage of Assets) | oef_ExpensesOverAssets | 1.32% | ||||||||||
| Expense Example, with Redemption, 1 Year | oef_ExpenseExampleYear01 | $ 134 | ||||||||||
| Expense Example, with Redemption, 3 Years | oef_ExpenseExampleYear03 | 418 | ||||||||||
| Expense Example, with Redemption, 5 Years | oef_ExpenseExampleYear05 | 723 | ||||||||||
| Expense Example, with Redemption, 10 Years | oef_ExpenseExampleYear10 | 1,590 | ||||||||||
| Expense Example, No Redemption, 1 Year | oef_ExpenseExampleNoRedemptionYear01 | 134 | ||||||||||
| Expense Example, No Redemption, 3 Years | oef_ExpenseExampleNoRedemptionYear03 | 418 | ||||||||||
| Expense Example, No Redemption, 5 Years | oef_ExpenseExampleNoRedemptionYear05 | 723 | ||||||||||
| Expense Example, No Redemption, 10 Years | oef_ExpenseExampleNoRedemptionYear10 | $ 1,590 | ||||||||||
| INVESCO Health Care Fund | INVESCO Health Care Fund - Class A | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Maximum Sales Charge Imposed on Purchases (as a percentage of Offering Price) | oef_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice | 5.50% | ||||||||||
| Maximum Deferred Sales Charge (as a percentage of Offering Price) | oef_MaximumDeferredSalesChargeOverOfferingPrice | 0.00% | [2] | |||||||||
| Management Fees (as a percentage of Assets) | oef_ManagementFeesOverAssets | 0.64% | ||||||||||
| Distribution and Service (12b-1) Fees | oef_DistributionAndService12b1FeesOverAssets | 0.25% | ||||||||||
| Other Expenses (as a percentage of Assets): | oef_OtherExpensesOverAssets | 0.17% | ||||||||||
| Acquired Fund Fees and Expenses | oef_AcquiredFundFeesAndExpensesOverAssets | 0.01% | ||||||||||
| Expenses (as a percentage of Assets) | oef_ExpensesOverAssets | 1.07% | ||||||||||
| Expense Example, with Redemption, 1 Year | oef_ExpenseExampleYear01 | $ 653 | ||||||||||
| Expense Example, with Redemption, 3 Years | oef_ExpenseExampleYear03 | 872 | ||||||||||
| Expense Example, with Redemption, 5 Years | oef_ExpenseExampleYear05 | 1,108 | ||||||||||
| Expense Example, with Redemption, 10 Years | oef_ExpenseExampleYear10 | 1,784 | ||||||||||
| Expense Example, No Redemption, 1 Year | oef_ExpenseExampleNoRedemptionYear01 | 653 | ||||||||||
| Expense Example, No Redemption, 3 Years | oef_ExpenseExampleNoRedemptionYear03 | 872 | ||||||||||
| Expense Example, No Redemption, 5 Years | oef_ExpenseExampleNoRedemptionYear05 | 1,108 | ||||||||||
| Expense Example, No Redemption, 10 Years | oef_ExpenseExampleNoRedemptionYear10 | $ 1,784 | ||||||||||
| INVESCO Health Care Fund | INVESCO Health Care Fund - Class C | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Maximum Sales Charge Imposed on Purchases (as a percentage of Offering Price) | oef_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice | 0.00% | ||||||||||
| Maximum Deferred Sales Charge (as a percentage of Offering Price) | oef_MaximumDeferredSalesChargeOverOfferingPrice | 1.00% | ||||||||||
| Management Fees (as a percentage of Assets) | oef_ManagementFeesOverAssets | 0.64% | ||||||||||
| Distribution and Service (12b-1) Fees | oef_DistributionAndService12b1FeesOverAssets | 1.00% | ||||||||||
| Other Expenses (as a percentage of Assets): | oef_OtherExpensesOverAssets | 0.17% | ||||||||||
| Acquired Fund Fees and Expenses | oef_AcquiredFundFeesAndExpensesOverAssets | 0.01% | ||||||||||
| Expenses (as a percentage of Assets) | oef_ExpensesOverAssets | 1.82% | ||||||||||
| Expense Example, with Redemption, 1 Year | oef_ExpenseExampleYear01 | $ 285 | ||||||||||
| Expense Example, with Redemption, 3 Years | oef_ExpenseExampleYear03 | 573 | ||||||||||
| Expense Example, with Redemption, 5 Years | oef_ExpenseExampleYear05 | 985 | ||||||||||
| Expense Example, with Redemption, 10 Years | oef_ExpenseExampleYear10 | 1,940 | ||||||||||
| Expense Example, No Redemption, 1 Year | oef_ExpenseExampleNoRedemptionYear01 | 185 | ||||||||||
| Expense Example, No Redemption, 3 Years | oef_ExpenseExampleNoRedemptionYear03 | 573 | ||||||||||
| Expense Example, No Redemption, 5 Years | oef_ExpenseExampleNoRedemptionYear05 | 985 | ||||||||||
| Expense Example, No Redemption, 10 Years | oef_ExpenseExampleNoRedemptionYear10 | $ 1,940 | ||||||||||
| INVESCO Health Care Fund | INVESCO Health Care Fund - Investor Class | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Maximum Sales Charge Imposed on Purchases (as a percentage of Offering Price) | oef_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice | 0.00% | ||||||||||
| Maximum Deferred Sales Charge (as a percentage of Offering Price) | oef_MaximumDeferredSalesChargeOverOfferingPrice | 0.00% | ||||||||||
| Management Fees (as a percentage of Assets) | oef_ManagementFeesOverAssets | 0.64% | ||||||||||
| Distribution and Service (12b-1) Fees | oef_DistributionAndService12b1FeesOverAssets | 0.25% | ||||||||||
| Other Expenses (as a percentage of Assets): | oef_OtherExpensesOverAssets | 0.17% | ||||||||||
| Acquired Fund Fees and Expenses | oef_AcquiredFundFeesAndExpensesOverAssets | 0.01% | ||||||||||
| Expenses (as a percentage of Assets) | oef_ExpensesOverAssets | 1.07% | ||||||||||
| Expense Example, with Redemption, 1 Year | oef_ExpenseExampleYear01 | $ 109 | ||||||||||
| Expense Example, with Redemption, 3 Years | oef_ExpenseExampleYear03 | 340 | ||||||||||
| Expense Example, with Redemption, 5 Years | oef_ExpenseExampleYear05 | 590 | ||||||||||
| Expense Example, with Redemption, 10 Years | oef_ExpenseExampleYear10 | 1,306 | ||||||||||
| Expense Example, No Redemption, 1 Year | oef_ExpenseExampleNoRedemptionYear01 | 109 | ||||||||||
| Expense Example, No Redemption, 3 Years | oef_ExpenseExampleNoRedemptionYear03 | 340 | ||||||||||
| Expense Example, No Redemption, 5 Years | oef_ExpenseExampleNoRedemptionYear05 | 590 | ||||||||||
| Expense Example, No Redemption, 10 Years | oef_ExpenseExampleNoRedemptionYear10 | $ 1,306 | ||||||||||
| INVESCO Health Care Fund | INVESCO Health Care Fund - Class Y | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Maximum Sales Charge Imposed on Purchases (as a percentage of Offering Price) | oef_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice | 0.00% | ||||||||||
| Maximum Deferred Sales Charge (as a percentage of Offering Price) | oef_MaximumDeferredSalesChargeOverOfferingPrice | 0.00% | ||||||||||
| Management Fees (as a percentage of Assets) | oef_ManagementFeesOverAssets | 0.64% | ||||||||||
| Distribution and Service (12b-1) Fees | oef_DistributionAndService12b1FeesOverAssets | 0.00% | ||||||||||
| Other Expenses (as a percentage of Assets): | oef_OtherExpensesOverAssets | 0.17% | ||||||||||
| Acquired Fund Fees and Expenses | oef_AcquiredFundFeesAndExpensesOverAssets | 0.01% | ||||||||||
| Expenses (as a percentage of Assets) | oef_ExpensesOverAssets | 0.82% | ||||||||||
| Expense Example, with Redemption, 1 Year | oef_ExpenseExampleYear01 | $ 84 | ||||||||||
| Expense Example, with Redemption, 3 Years | oef_ExpenseExampleYear03 | 262 | ||||||||||
| Expense Example, with Redemption, 5 Years | oef_ExpenseExampleYear05 | 455 | ||||||||||
| Expense Example, with Redemption, 10 Years | oef_ExpenseExampleYear10 | 1,014 | ||||||||||
| Expense Example, No Redemption, 1 Year | oef_ExpenseExampleNoRedemptionYear01 | 84 | ||||||||||
| Expense Example, No Redemption, 3 Years | oef_ExpenseExampleNoRedemptionYear03 | 262 | ||||||||||
| Expense Example, No Redemption, 5 Years | oef_ExpenseExampleNoRedemptionYear05 | 455 | ||||||||||
| Expense Example, No Redemption, 10 Years | oef_ExpenseExampleNoRedemptionYear10 | $ 1,014 | ||||||||||
| INVESCO Health Care Fund | INVESCO Health Care Fund - Class R6 | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Maximum Sales Charge Imposed on Purchases (as a percentage of Offering Price) | oef_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice | 0.00% | ||||||||||
| Maximum Deferred Sales Charge (as a percentage of Offering Price) | oef_MaximumDeferredSalesChargeOverOfferingPrice | 0.00% | ||||||||||
| Management Fees (as a percentage of Assets) | oef_ManagementFeesOverAssets | 0.64% | ||||||||||
| Distribution and Service (12b-1) Fees | oef_DistributionAndService12b1FeesOverAssets | 0.00% | ||||||||||
| Other Expenses (as a percentage of Assets): | oef_OtherExpensesOverAssets | 0.07% | ||||||||||
| Acquired Fund Fees and Expenses | oef_AcquiredFundFeesAndExpensesOverAssets | 0.01% | ||||||||||
| Expenses (as a percentage of Assets) | oef_ExpensesOverAssets | 0.72% | ||||||||||
| Expense Example, with Redemption, 1 Year | oef_ExpenseExampleYear01 | $ 74 | ||||||||||
| Expense Example, with Redemption, 3 Years | oef_ExpenseExampleYear03 | 230 | ||||||||||
| Expense Example, with Redemption, 5 Years | oef_ExpenseExampleYear05 | 401 | ||||||||||
| Expense Example, with Redemption, 10 Years | oef_ExpenseExampleYear10 | 894 | ||||||||||
| Expense Example, No Redemption, 1 Year | oef_ExpenseExampleNoRedemptionYear01 | 74 | ||||||||||
| Expense Example, No Redemption, 3 Years | oef_ExpenseExampleNoRedemptionYear03 | 230 | ||||||||||
| Expense Example, No Redemption, 5 Years | oef_ExpenseExampleNoRedemptionYear05 | 401 | ||||||||||
| Expense Example, No Redemption, 10 Years | oef_ExpenseExampleNoRedemptionYear10 | $ 894 | ||||||||||
| MSCI World Health Care Index (Net) (reflects reinvested dividends net of withholding taxes, but reflects no deduction for fees, expenses or other taxes) | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 14.83% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 6.43% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 8.14% | ||||||||||
| MSCI World IndexSM (Net) (reflects reinvested dividends net of withholding taxes, but reflects no deduction for fees, expenses or other taxes) | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 21.09% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 12.15% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 12.17% | ||||||||||
| S&P Composite 1500® Health Care Index (reflects no deduction for fees, expenses or taxes) | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 13.71% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 7.54% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 9.81% | ||||||||||
| INVESCO Health Care Fund - Class R | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 15.22% | [3] | |||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 3.46% | [3] | |||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 6.12% | [3] | |||||||||
| Performance Inception Date | oef_PerfInceptionDate | Sep. 30, 2025 | [3] | |||||||||
| INVESCO Health Care Fund - Class A | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | (11.71%) | ||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | 15.46% | ||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | 0.46% | ||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | 32.00% | ||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | 14.45% | ||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | 12.19% | ||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | (13.53%) | ||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | 3.05% | ||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | 3.97% | ||||||||||
| Annual Return [Percent] | oef_AnnlRtrPct | 15.49% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 9.15% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 2.55% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 5.79% | ||||||||||
| Performance Inception Date | oef_PerfInceptionDate | Aug. 07, 1989 | ||||||||||
| INVESCO Health Care Fund - Class A | After Taxes on Distributions | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 7.74% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 1.04% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 4.34% | ||||||||||
| INVESCO Health Care Fund - Class A | After Taxes on Distributions and Sales | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 6.40% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 1.87% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 4.39% | ||||||||||
| INVESCO Health Care Fund - Class C | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 13.57% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 2.94% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 5.75% | ||||||||||
| Performance Inception Date | oef_PerfInceptionDate | Mar. 01, 1999 | ||||||||||
| INVESCO Health Care Fund - Investor Class | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 15.48% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 3.72% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 6.38% | ||||||||||
| Performance Inception Date | oef_PerfInceptionDate | Jul. 15, 2005 | ||||||||||
| INVESCO Health Care Fund - Class Y | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 15.76% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 3.98% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 6.65% | ||||||||||
| Performance Inception Date | oef_PerfInceptionDate | Oct. 03, 2008 | ||||||||||
| INVESCO Health Care Fund - Class R6 | ||||||||||||
| Prospectus [Line Items] | oef_ProspectusLineItems | |||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 15.87% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 4.07% | ||||||||||
| Average Annual Return, Percent | oef_AvgAnnlRtrPct | 6.69% | [4] | |||||||||
| Performance Inception Date | oef_PerfInceptionDate | Apr. 04, 2017 | ||||||||||
| ||||||||||||